The Current Ratio as of December 2024 (TTM) for Alpine Immune Sciences, Inc. (ALPN) is 9.56

According to Alpine Immune Sciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.56. This represents a change of 52.29% compared to the average of 6.28 of the last 4 quarters.

Alpine Immune Sciences, Inc. (ALPN) Historical Current Ratio (quarterly & annually)

How has ALPN Current Ratio performed in the past?

The mean historical Current Ratio of Alpine Immune Sciences, Inc. over the last ten years is 11.35. The current 9.56 Current Ratio has changed 8.32% with respect to the historical average. Over the past ten years (40 quarters), ALPN's Current Ratio was at its highest in in the December 2017 quarter at 43.56. The Current Ratio was at its lowest in in the June 2014 quarter at 0.

Alpine Immune Sciences, Inc. (ALPN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alpine Immune Sciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alpine Immune Sciences, Inc. (ALPN) Average Current Ratio

How has ALPN Current Ratio performed in the past?

The current Current Ratio of Alpine Immune Sciences, Inc. (ALPN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Alpine Immune Sciences, Inc. (ALPN) Current Ratio vs. Peers

How is ALPN’s Current Ratio compared to its peers?

Alpine Immune Sciences, Inc.’s Current Ratio is less than Terns Pharmaceuticals, Inc. (0), less than Day One Biopharmaceuticals, Inc. (32.99), less than Acumen Pharmaceuticals, Inc. (14.62), less than Amylyx Pharmaceuticals, Inc. (10.43), greater than MoonLake Immunotherapeutics (4.55), less than Anebulo Pharmaceuticals, Inc. (25.51), greater than Adagene Inc. (3.45), greater than Acrivon Therapeutics, Inc. Common Stock (2.50), less than AnaptysBio, Inc. (12.75), less than Mineralys Therapeutics, Inc. (10.23), greater than Tenaya Therapeutics, Inc. (8.55), greater than Bicycle Therapeutics plc (5.27), less than IGM Biosciences, Inc. (17.13), greater than Monte Rosa Therapeutics, Inc. (5.22), greater than Stoke Therapeutics, Inc. (6.03), greater than null (5.09),

Build a custom stock screener for Alpine Immune Sciences, Inc. (ALPN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alpine Immune Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alpine Immune Sciences, Inc. (ALPN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alpine Immune Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.